Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

IMW 2019

Highlights

View all
1:40
Key topics from IMW 2019
Maria-Victoria Mateos • 12 Sep 2019
1:57
Paul Richardson’s angiopathy highlights
Paul Richardson • 13 Sep 2019

Expert Discussions

View all
10:42
Highlights from IMW 2019 Part I
Francesca Gay et al. • 25 Sep 2019
11:36
An MRD discussion: when, who and how
Faith Davies et al. • 14 Sep 2019

MRD

View all
1:22
NGS or flow-based MRD in myeloma? A need for consistency
Bruno Paiva • 12 Sep 2019
1:32
MRD in myeloma: an important surrogate for PFS
Bruno Paiva • 12 Sep 2019

Transplantation

View all
5:24
The role of transplantation in the treatment of multiple myeloma
David Siegel • 13 Sep 2019
1:55
MM: when is allogeneic transplant is the right answer?
Amrita Krishnan • 13 Sep 2019

Amyloidosis

View all
1:58
Implications of IMW 2019 on nursing practices
Tanya Burton • 14 Sep 2019
3:00
MRD as a prognostic tool in amyloidosis
Surbhi Sidana • 15 Sep 2019

Waldenström’s

View all
3:23
Progression risk stratification of asymptomatic WM
Romanos Sklavenitis-Pistofidis • 14 Sep 2019
2:13
Founding precision therapy for 1q-amplified multiple myeloma
Romanos Sklavenitis-Pistofidis • 14 Sep 2019

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals